Abstract LB-179: Phase I trial of relapsed neuroblastoma with DFMO alone and in combination with etoposide.
Year: 2013
Type: conference-abstract
Source: Cancer Research
Authors: Giselle L. Sholler, Eugene W. Gerner, Genevieve Bergendahl, Bonnie J. LaFleur, Alyssa VanderWerff, Takamaru Ashikaga, William Ferguson, William Roberts, Don Eslin, Joel Kaplan, Jacqueline M. Kraveka, Deanna Mitchell, Kathleen Neville, Randal Wada, Nehal Parikh, Leonard Sender, Timothy Higgins, Andre Bachmann
Institutions: Van Andel Institute, Cancer Prevention Pharmaceuticals (United States), 3D Medicines, Inc. (China), University of Vermont, Cardinal Glennon Children’s Medical Center, Rady Children's Hospital-San Diego, Arnold Palmer Hospital for Children, Levine Children's Hospital, Medical University of South Carolina, Helen DeVos Children's Hospital, Children's Mercy Hospital, Kapiolani Medical Center for Women and Children, Connecticut Children's Medical Center, Children's Hospital of Orange County, University of Vermont Medical Center, University of Hawaii at Hilo
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2068243980